SARS News and Research

RSS

Myocarditis risk greater after SARS-CoV-2 infection than after first dose of COVID-19 vaccine

Among nearly 43 million people in England, ages 13 and older, who received at least one dose and up to 3 doses of a COVID-19 vaccine, fewer than 3,000 people (0.007%) were hospitalized or died with myocarditis, or inflammation of the heart muscle, during the study period of December 1, 2020 through December 15, 2021.

22 Aug 2022

First two years of the COVID-19 pandemic caused excess deaths in the United States

In a new study, researchers used seasonal autoregressive integrated moving averages to estimate excess mortality, defined as the difference between the number of observed and expected deaths, in the US.

22 Aug 2022

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

In a newly released study, researchers explored the sotrovimab uptake for severe COVID-19 prophylaxis and its safety across the community populations in England.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

A recent study has demonstrated the antiviral effectiveness of cetylpyridinium chloride against SARS-CoV-2 infection.

22 Aug 2022

Study shows rapid waning of immune protection due to prior BA.1/BA.2 infection against BA.5 breakthrough infection

Researchers investigated the waning of protective immunity conferred by prior infection by Omicron sub-variants BA.1, BA.2 towards its most recent sub-variant BA.5.

22 Aug 2022

What is the prevalence of bacterial co-infections during COVID-19?

Researchers evaluated the characteristics and prevalence of bacterial co-infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Aug 2022

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Researchers conducted a phase III clinical trial to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine, in preventing progression to severe COVID-19.

22 Aug 2022

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

Researchers explored the durability of immunity imparted by the SARS-CoV-2 adjuvanted subunit vaccine against the Omicron variant.

22 Aug 2022

How do different social settings impact super-spreading event formation and onward transmission generation?

Researchers analyzed the influence of nightlife environments in sustained COVID-19 transmission.

22 Aug 2022

Risk trajectories of post-COVID neurological and psychiatric outcomes

Researchers examined the evolution of incidence or relative risk of neuropsychiatric diagnoses for two years in patients who had recovered from COVID-19.

22 Aug 2022

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Researchers explored how the natural alterations inside the SARS-CoV-2 glycan barrier affect the spike protein dynamics.

22 Aug 2022

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

A recent study examines the potential effects of tobacco use on COVID-19.

21 Aug 2022

Consumption of ultra-processed foods increases risk of COVID-19

Researchers explore the association between consumption of ultra-processed foods and risk of SARS-CoV-2 infection.

21 Aug 2022

The effect of different SARS-CoV-2 variants on maternal outcomes

Researchers evaluate the association between severe maternal morbidities and SARS-CoV-2 infection.

21 Aug 2022

Cedars-Sinai investigators propose a theory for the cause of post-COVID syndromes

Investigators at Cedars-Sinai have proposed a theory for how SARS-CoV-2, the virus that causes COVID-19, infects the body. Their hypothesis, published in Frontiers in Immunology, could explain why some people still have symptoms long after the initial infection.

19 Aug 2022

SARS News and Research

Myocarditis risk greater after SARS-CoV-2 infection than after first dose of COVID-19 vaccine

First two years of the COVID-19 pandemic caused excess deaths in the United States

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

Study shows rapid waning of immune protection due to prior BA.1/BA.2 infection against BA.5 breakthrough infection

What is the prevalence of bacterial co-infections during COVID-19?

The effectiveness of three repurposed drugs in preventing serious SARS-CoV-2 infection in non-hospitalized adults

Durability of immune protection after booster immunization with COVID-19 adjuvanted subunit vaccine against the immune-evasive Omicron BA.1 variant

How do different social settings impact super-spreading event formation and onward transmission generation?

Risk trajectories of post-COVID neurological and psychiatric outcomes

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

Consumption of ultra-processed foods increases risk of COVID-19

The effect of different SARS-CoV-2 variants on maternal outcomes

Cedars-Sinai investigators propose a theory for the cause of post-COVID syndromes

SARS-CoV-2 mRNA vaccination reveals HIV hiding in immune cells

New study estimates how long people with mild COVID-19 are infectious

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers investigate human monkeypox infection without sexual exposure or viral prodrome

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News